# US 2021/0079352 A1 · Biomimetic lamellar tissue scaffolds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0079352 A1
- Document ID: US20210079352A1
- Status: Published application
- Kind: A1
- Application number: 17/106,129
- Filed: 2020-11-29
- Published: 2021-03-18
- Earliest claimed: 2018-12-05
- Assignees: Ultra Small Fibers, LLC
- Applicants: Ultra Small fibers, LLC
- Inventors: William Hudson Hofmeister; Robert A. Van Wyke; Christopher P. Dougherty; Collin David Anderson
- Web page: https://patentgrep.com/patent/US20210079352A1

## CPC

- A61F 2/0077: {Special surfaces of prostheses, e.g. for improving ingrowth (A61F2/30767 takes precedence)}
- C12N 5/0667: {Adipose-derived stem cells [ADSC]; Adipose stromal stem cells}
- A61F 2/02: Prostheses implantable into the body
- A61F 2/08: Muscles; Tendons; Ligaments
- A61F 2/30756: {Cartilage endoprostheses (A61F2/3603 takes precedence)}
- A61K 38/39: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- A61L 15/225: {Mixtures of macromolecular compounds}
- A61L 15/32: Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin {(A61L15/225 takes precedence)}
- A61L 15/44: Medicaments
- A61L 15/58: Adhesives
- A61L 27/225: {Fibrin; Fibrinogen}
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61F 2002/0086: {for preferentially controlling or promoting the growth of specific types of cells or tissues}
- A61F 2002/30766: {Scaffolds for cartilage ingrowth and regeneration}
- A61F 2250/0031: made from both resorbable and non-resorbable prosthetic parts, e.g. adjacent parts
- A61L 2300/412: Tissue-regenerating or healing or proliferative agents
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- A61L 2430/06: for cartilage reconstruction, e.g. meniscus
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES

## Abstract

A biomimetic lamellar tissue scaffold for tissue regeneration comprises a plurality of lamellae formed of a polymer film and each having a first surface and a second surface. A patterned array of polymer nanofibers protrudes from the first surface of each lamella of the plurality. The lamellae form a plurality of interlamellar spaces between the first and second surfaces of adjacent lamellae. Protuberances formed on the first surface of each lamella maintain the interlamellar spaces. The arrays of polymer nanofibers on the first lamellar surface of each lamella protrude into the interlamellar spaces between adjacent lamellae and are configured to influence the propagation and differentiation of cells populated to or recruited to the scaffold.

## Claims

### Claim 1

A scaffold for tissue regeneration comprising:
a plurality of lamellae formed of a polymer film and each having a first surface with a patterned array of polymer nanofibers protruding from said first surface, and a second surface;
a plurality of interlamellar spaces formed between said first surfaces of said lamellae and said second surfaces of adjacent said lamellae; and
a plurality of protuberances formed on said lamellae to maintain said interlamellar spaces;
wherein said array of polymer nanofibers on said first lamellar surfaces protrude into said interlamellar spaces; and
wherein said patterned array is configured to influence the propagation and differentiation of cells populated to or recruited to said scaffold.

### Claim 2 (depends on 1)

The scaffold of claim 1 wherein said lamellae further comprise perforations between said first surface and said second surface.

### Claim 3 (depends on 1)

The scaffold of claim 1 wherein said polymer film is bioabsorbable.

### Claim 4 (depends on 1)

The scaffold of claim 1 wherein said polymer film is treated with another polymer such as poly-L-lysine or poly-D-lysine, or a biological substance such as proteoglycans (proteoglycan 4) or glycoproteins to improve surface wetting and cell attachment.

### Claim 5 (depends on 1)

The scaffold of claim 1 wherein said lamellae are oriented perpendicular to the plane of said scaffold

### Claim 6 (depends on 1)

The scaffold of claim 1 wherein said lamellae are oriented parallel to the plane of said scaffold.

### Claim 7 (depends on 1)

The scaffold of claim 1 wherein said lamellae are arranged as parallel layers.

### Claim 8 (depends on 1)

The scaffold of claim 1 wherein said lamellae form a coil.

### Claim 9 (depends on 1)

The scaffold of claim 1 wherein said patterned array of nanofibers comprises rows of nanofibers.

### Claim 10 (depends on 1)

The scaffold of claim 1 wherein said patterned array is uniform over said first surface of said lamella.

### Claim 11 (depends on 1)

The scaffold of claim 1 wherein said first surface of said lamella has a first region with a first said patterned array, and a second region with a second said patterned array.

### Claim 12

A method for treating a patient using a biomimetic scaffold comprising the steps of:
providing a scaffold formed of one or more lamellae with a nanofiber array formed on a first surface of said one or more lamellae, said scaffold further comprising one or more interlamellar spaces wherein said nanofiber array protrudes into said interlamellar spaces;
preparing a treatment site on said patient to receive said scaffold; and
implanting said scaffold at said site.

### Claim 13 (depends on 12)

The method of claim 12 further comprising the step of affixing said scaffold at said site.

### Claim 14 (depends on 12)

The method of claim 12 wherein the fixation method comprises using a fibrin glue.

### Claim 15 (depends on 12)

The method of claim 12 wherein the fixation method comprises using suture or mechanical fixation.

### Claim 16 (depends on 12)

The method of claim 12 wherein said treatment site comprises an articular lesion.

### Claim 17 (depends on 16)

The method of claim 16 wherein preparing said treatment site comprises performing a microfracture procedure.

### Claim 18 (depends on 12)

The method of claim 12 wherein preparing said treatment site comprises the application of a bioactive material to the site prior to implanting the scaffold.

### Claim 19 (depends on 12)

The method of claim 12 wherein said scaffold is immersed in a biologic fluid containing stem cells prior to implanting.

### Claim 20

A method for creating a tissue structure for implantation in a patient comprising the steps of:
providing a scaffold formed of one or more lamellae with a nanofiber array formed on a first surface of said one or more lamellae, said scaffold further comprising one or more interlamellar spaces wherein said nanofiber array protrudes into said interlamellar spaces, and said scaffold is configured to mimic a native tissue structure;
submerging said scaffold in a biologic solution comprising stem cells;
maintaining said scaffold and biologic solution in a suitable bioreactor until said scaffold is replaced by extracellular matrix and said tissue structure is complete; and
removing said tissue structure from said bioreactor;
wherein said nanofiber array is configured for optimal stem cell propagation and differentiation into a predetermined cell type.
